Delgado-Ortiz L, Carsin AE, Merino J, Cobo I, Koch S, Goldberg X, Chevance G, Bosch de Basea M, Castano-Vinyals G, Espinosa A, Carreras A, Cortes Martinez B, Straif K, de Cid R, Kogevinas M, Garcia-Aymerich J. Changes in population health-related behaviors during a COVID-19 surge: a natural experiment. Ann Behav Med. 2023 Apr 5;57(3):216-26. doi: 10.1093/abm/kaac054
Williams VS, Nelson LM, Fehnel SE, MacDougall J, Carson RT, Tourkodimitris S, Kurtz C, Baird MJ, Johnston JM. Psychometric validation of symptom severity measures in irritable bowel syndrome with constipation. Aliment Pharmacol Ther. 2014 Aug;40(3):298-308. doi: 10.1111/apt.12830
Rubin DT, Mody R, Davis KL, Wang CC. Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease. Aliment Pharmacol Ther. 2014 May;39(10):1143-55. doi: 10.1111/apt.12727
Huerta C, Rivero E, Montoro MA, García-Rodriguez LA. Risk factors for intestinal ischaemia among patients registered in a UK primary care database: a nested case-control study. Aliment Pharmacol Ther. 2011 Apr;33(8):969-78. doi: 10.1111/j.1365-2036
Earnshaw SR, Klok RM, Iyer S, McDade C. Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis. Aliment Pharmacol Ther. 2010 Apr 1;31(8):911-21.
Cook SF, Lanza L, Zhou X, Sweeney CT, Goss D, Hollis K, Mangel AW, Fehnel SE. Gastrointestinal side effects in chronic opioid users: results from a population-based survey. Aliment Pharmacol Ther. 2008 Jun 15;27(12):1224-32.
Tennis P, Andrews E, Hickman P, Miller D, Hollis KA, Cook S. The relationship between dosing of alosetron and discontinuation patterns reported by patients participating in a follow-up programme. Aliment Pharmacol Ther. 2007 Feb 1;25(3):317-22.
Miller DP, Bennett L, Hollis KA, Tennis P, Cook SF, Andrews E. A patient follow-up survey programme for alosetron: assessing compliance to and effectiveness of the risk management programme. Aliment Pharmacol Ther. 2006 Sep 1;24(5):869-78.
Mangel AW, Fehnel SE. Global endpoints in functional gastrointestinal disease. Aliment Pharmacol Ther. 2005 Dec 1;22(11-12):1162-3.
Andrews EB, Eaton SC, Hollis KA, Hopkins JS, Ameen VZ, Hamm LR, Mangel AW, Tennis P, Cook SF. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther. 2005 Nov 10;22:935-42.
King TK, Britt DM, Day A. Changes in body esteem and sexual satisfaction in obese females enrolled in a weight loss program. Ann Behav Med. 2001;23(Suppl):S023.
King TK, Britt DM, Lloyd E. Demographic and psychological characteristics of obese smokers presenting for weight loss treatment. Ann Behav Med. 2001;23(Suppl):S027.
Vakil N, Hahn B, McSorley DJ. Recurrent symptoms and gastro-oesophageal reflux disease in patient with duodenal ulcer treated for helicobacter pylori infection. Aliment Pharmacol Ther. 2000 Jan;14(1):45-51.
Camilleri M, Mayer EA, Drossman DA, Heath AT, Dukes GE, McSorley DJ, Kong S, Mangel AW, Northcutt AR. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther. 1999 Sep;13(9):1149-59.
Britt (DiBenedetti) DM, Seaton M, Cohan LM, Collins FL. Cigarette smoking and chewing gum: response to a laboratory-induced stressor. Poster presented at the Association for the Behavioral Sciences and Medical Education Conference; 1999. [abstract] Ann Behav Med. 1999; 21(Suppl):S039.
Cohen LM, Britt (DiBenedetti) DM, Collins FL, al’Absi M. A multimodal assessment of the effect of chewing gum on tobacco withdrawal. Poster presented at the Association for the Behavioral Sciences and Medical Education Conference; 1999. [abstract] Ann Behav Med. 1999; 21(Suppl):S039.
Peterson WL, Ciociola AA, Sykes DL, McSorley DJ, Webb DD. Ranitidine bismuth citrate (tritec) plus clarithromycin is effective for healing duodenal ulcers, eradicating h.pylori, and reducing ulcer recurrence. Aliment Pharmacol Ther. 1996;10(3):251-61.
Stetson B, Dubbert P, Rahn J, Wilner B, Mercury M, Britt (DiBenedetti) D. Gender differences in the cognitive appraisal of exercise relapse. Poster presented at the 1993 Society of Behavioral Medicine Conference; 1993. [abstract] Ann Behav Med. 1993 Jun 1; 15(2-3):S167. doi: 10.1093/abm/15.2-3.164
Stetson B, Dubbert P, Wilner B, Rahn J, Mercury M, Britt (DiBenedetti) D. Influence of biological and psychosocial factors on activity in free-exercising adults. Poster presented at the 1993 Society of Behavioral Medicine Conference; 1993. [abstract] Ann Behav Med. 1993; 15(Suppl):S167.
Smith PO, Stetson B, Dubbert P, Mercury M, Rahn J, Britt (DiBenedetti) DM. Body image differences in adult exercising women. Poster presented at the 1993 Society of Behavioral Medicine Conference; 1993. [abstract] Ann Behav Med. 1993; 15(Suppl):S167.